COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,542 Articles (22,881 medRxiv, 8,661 bioRxiv)

Most recent first Previous |  Page 1339: Articles 13381-13390  | Next

Neutrophil-epithelial interactions augment infectivity and pro-inflammatory responses to SARS-CoV-2 infection
Calvert, B. A., Quiroz, E. J., Lorenzana, Z., Doan, N., Kim, S., Senger, C. N., Wallace, W. D., Salomon, M., Henley, J., Ryan, A. L.
10.1101/2021.08.09.455472 — Posted: 2021-08-10
In-House, Rapid, and Low-Cost SARS-CoV-2 Spike Gene Sequencing Protocol to Identify Variants of Concern Using Sanger Sequencing
Alhamlan, F., Bakheet, D., Bohol, M., Alsanea, M., Alahaideb, B., Alhadeq, F., Alsuwairi, F., Al-Abdulkareem, M., Asiri, M., Almaghrabi, R., Altamimi, S., Mutabagani, M., Althawadi, S., Al-Qahtani, A.
10.1101/2021.08.09.21261723 — Posted: 2021-08-10
Symptoms that predict positive COVID-19 testing and hospitalization: an analysis of 9,000 patients
Jalalizadeh, M., Leme, P. A. F., Buosi, K., Dionato, F. A. V., Giacomelli, C. F., Dal Col, L. S. B., Ferrari, K. L., Pagliarone, A. C., Gon, L. M., Cezar, D. F. O., Esfahani, A. A., Reis, L. O.
10.1101/2021.08.09.21261729 — Posted: 2021-08-10
Use of compressed sensing to expedite high-throughput diagnostic testing for COVID-19 and beyond
Waldstein, K. A., Yi, J., Cho, M. M., Mudumbai, R., Wu, X., Varga, S. M., Xu, W.
10.1101/2021.08.09.21261669 — Posted: 2021-08-10
Full vaccination suppresses SARS-CoV-2 delta variant mutation frequency
Yeh, T.-Y., Contreras, G. P.
10.1101/2021.08.08.21261768 — Posted: 2021-08-10 Discussion: Onsite | Offsite
Cryptic Transmission of the Delta Variant AY.3 Sublineage of SARS-CoV-2 among Fully Vaccinated Patients on an Inpatient Ward
Linsenmeyer, K., Gupta, K., Madjarov, R., Charness, M. E.
10.1101/2021.08.05.21261562 — Posted: 2021-08-10 Discussion: Onsite
Mixed invasive molds among COVID-19 patients
Singh, V., Prasad, A., Panda, P. K., Totaganti, M., Tyagi, A., Thaduri, A., Rao, S., Bairwa, M., Singh, A. K.
10.1101/2021.08.09.21261555 — Posted: 2021-08-10
A multidimensional cross-sectional analysis of COVID-19 seroprevalence among a police officer cohort: The PoliCOV-19 study
Sendi, P., Baldan, R., Thierstein, M., Widmer, N., Gowland, P., Gahl, B., Buechi, A. E., Guentensperger, D., Wider, M., Blum, M. R., Tinguely, C., Maillat, C., Theel, E. S., Berbari, E., Dijkman, R., Niederhauser, C.
10.1101/2021.08.09.21261789 — Posted: 2021-08-10
Genomic analysis of SARS-CoV-2 variants of concern identified from the ChAdOx1 nCoV-19 immunized patients from Southwest part of Bangladesh
Al-Emran, H. M., Hasan, M. S., Setu, M. A. A., Rahman, M. S., Alam, A. R. U., Sarkar, S. L., Islam, M. T., Islam, M. R., Rahman, M. M., Islam, M. A., Jahid, I. K., Hossain, M. A.
10.1101/2021.08.09.21261778 — Posted: 2021-08-10
Predictive Analysis of COVID-19 Spread in Sri Lanka using an Adaptive Compartmental Model: Susceptible-Exposed-Infected-Recovered-Dead (SEIRD) Model
Rajapaksha, N. U., Wijesinghe, S. D., Jayasooriya, S. P., Weerasinghe, P. C., Gunawardana, I.
10.1101/2021.08.09.21261819 — Posted: 2021-08-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).